Abstract
Tumor size is known to be the most important prognostic factor for the survival of patients with cervical cancer [1,2]. For this reason, the International Federation of Gynecology and Obstetrics (FIGO) has subdivided stage IB cervical cancer on the basis of lesion size, with stage IB1 referring to lesions 4 cm or less and stage IB2 to lesions greater than 4 cm. However, this clinical staging system does not comprise the various pathologic factors that also predict prognosis [3,4]. The present study was designed to identify the independent patho-
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Gynecology and Obstetrics
Paper Title
Journal
Date
